Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03022630 · ClinicalTrials.gov registry record · NA
Palliative Care for Non-Malignant Diseases (COMPASS Trial)
A NA study, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT03022630 is a NA study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 63 participants.
The verdict
NCT03022630, a NA study, was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate, through a randomized controlled trial, the impact of integrated comprehensive palliative care services on time to first hospital readmission and other hospital utilization outcomes, quality of life, and patient/caregiver outcomes. The intervention includes comprehensive, standardized palliative care services for adult hepatology cirrhosis patients for which prognosis is poor.
Interventions
- OTHER Comprehensive Palliative Care services
- OTHER Usual hepatic care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2017-02-06 |
| Est. Completion | 2018-06-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03022630
The ClinicalTrials.gov registry entry for NCT03022630 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Comprehensive Palliative Care services is the first listed.
NCT03022630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03022630 about?
NCT03022630 is a clinical study titled "Palliative Care for Non-Malignant Diseases (COMPASS Trial)". The purpose of this study is to evaluate, through a randomized controlled trial, the impact of integrated comprehensive palliative care services on time to first hospital readmission and other hospital utilization outcomes, quality of life, and patient/caregiver outcomes. The intervention includes c...
What is the current status of trial NCT03022630?
This trial is currently terminated. It is a NA study. The enrollment target is 63 participants. The study started on 2017-02-06. Estimated completion is 2018-06-21.
What interventions are being tested in trial NCT03022630?
The interventions under investigation include: Comprehensive Palliative Care services (OTHER), Usual hepatic care (OTHER).
Who is sponsoring clinical trial NCT03022630?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.